Court confirms patients are relevant consumers in prescription-drug trademark confusion analysis
The Federal Court of Appeal has upheld a trademark injunction against Samsung and Biogen over their BYOOVIZ biosimilar, ruling that patients are relevant consumers in assessing confusion with Novartis’s trademark in...To view the full article, register now.
Already a subscriber? Click here to view full article